Acute promyelocytic leukemia, formerly a highly lethal disease, was re
cently shown to be highly responsive to treatment with the natural ret
inoid, all-trans retinoic acid. This compound induces terminal differe
ntiation of the malignant cells and produces complete remission in mos
t patients with this disease. The clinical response is due in part to
the presence of a chromosomal break that occurs in a gene that encodes
a nuclear retinoic acid receptor.